Literature DB >> 22659303

Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies.

Cynthia H Y Fu1, Herbert Steiner, Sergi G Costafreda.   

Abstract

We performed a systematic review and meta-analysis of neural predictors of response to the most commonly used, evidence based treatments in clinical practice, namely pharmacological and psychological therapies. Investigations of medication-free subjects suffering from a current major depressive episode who underwent positron emission tomography (PET) or functional or structural magnetic resonance imaging (MRI) scans prior to the initiation of treatment were reviewed. Results of 20 studies from 15 independent samples were included in the functional imaging meta-analysis and 9 studies from 6 independent samples in the structural neuroimaging meta-analysis. Regional activations with prognostic value include the well replicated finding that increased baseline activity in the anterior cingulate is predictive of a higher likelihood of improvement. As well, increased baseline activation in the insula and striatum is associated with higher likelihood of a poorer clinical response. Structural neuroimaging studies indicated that a decrease in right hippocampal volume is a statistically significant predictor of poorer treatment response. Overall, the predictive information that is measurable with brain imaging techniques is both multimodal and regionally distributed as it contains functional as well as structural correlates which encompass several brain regions within a frontostriatal-limbic network. To develop clinically relevant, prognostic markers will require high predictive accuracy at the level of the individual. Predicting clinical response will help to stratify patients and to identify at an early stage those patients who may require more intensive or combined therapies. We propose that structural and functional neuroimaging show significant potential for the development of prognostic markers of clinical response in the treatment of depression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659303     DOI: 10.1016/j.nbd.2012.05.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  108 in total

1.  Basolateral amygdala-ventromedial prefrontal cortex connectivity predicts cognitive behavioural therapy outcome in adults with obsessive-compulsive disorder.

Authors:  Miquel A Fullana; Xi Zhu; Pino Alonso; Narcís Cardoner; Eva Real; Clara López-Solà; Cinto Segalàs; Marta Subirà; Hanga Galfalvy; José M Menchón; H Blair Simpson; Rachel Marsh; Carles Soriano-Mas
Journal:  J Psychiatry Neurosci       Date:  2017-11       Impact factor: 6.186

Review 2.  Biomarkers in pediatric depression.

Authors:  Uma Rao
Journal:  Depress Anxiety       Date:  2013-08-22       Impact factor: 6.505

Review 3.  From psychiatric disorders to animal models: a bidirectional and dimensional approach.

Authors:  Zoe R Donaldson; René Hen
Journal:  Biol Psychiatry       Date:  2014-02-17       Impact factor: 13.382

4.  Diagnostic classification of unipolar depression based on resting-state functional connectivity MRI: effects of generalization to a diverse sample.

Authors:  Benedikt Sundermann; Stephan Feder; Heike Wersching; Anja Teuber; Wolfram Schwindt; Harald Kugel; Walter Heindel; Volker Arolt; Klaus Berger; Bettina Pfleiderer
Journal:  J Neural Transm (Vienna)       Date:  2016-12-31       Impact factor: 3.575

5.  Test-retest reliability of amygdala response to emotional faces.

Authors:  Colin L Sauder; Greg Hajcak; Mike Angstadt; K Luan Phan
Journal:  Psychophysiology       Date:  2013-10-16       Impact factor: 4.016

Review 6.  The role of machine learning in neuroimaging for drug discovery and development.

Authors:  Orla M Doyle; Mitul A Mehta; Michael J Brammer
Journal:  Psychopharmacology (Berl)       Date:  2015-05-28       Impact factor: 4.530

7.  Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Authors:  Oliver G Bosch; Fabrizio Esposito; Michael M Havranek; Dario Dornbierer; Robin von Rotz; Philipp Staempfli; Boris B Quednow; Erich Seifritz
Journal:  Neuropsychopharmacology       Date:  2017-05-31       Impact factor: 7.853

8.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

9.  Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.

Authors:  Wenjing Wei; Helmet T Karim; Chemin Lin; Akiko Mizuno; Carmen Andreescu; Jordan F Karp; Charles F Reynolds; Howard J Aizenstein
Journal:  J Clin Psychiatry       Date:  2018-10-23       Impact factor: 4.384

10.  A functional MRI marker may predict the outcome of electroconvulsive therapy in severe and treatment-resistant depression.

Authors:  J A van Waarde; H S Scholte; L J B van Oudheusden; B Verwey; D Denys; G A van Wingen
Journal:  Mol Psychiatry       Date:  2014-08-05       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.